Baricitinib Achieved Complete Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials. J of Skin 2025, 9 (1), s520. https://doi.org/10.25251/skin.9.supp.520.